Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
Ford and Geely Explore Strategic Manufacturing Partnership in Europe 
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment 
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock 
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies 
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks 
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate 
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences 
Instagram Outage Disrupts Thousands of U.S. Users 
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile 
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans 
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links 
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch 
AMARILLO, Texas, April 01, 2016 -- Maxor National Pharmacy Services, LLC (“Maxor” or the “Company”), a leading pharmacy services platform, today announced the retirement of John Ward, CEO of Maxor effective April 4. In October 2015, Mr. Ward had indicated his intention to retire by the end of 2016. He will remain on the Board of Directors and a significant investor in the Company.
Mike Ellis will be assuming the CEO role at Maxor. Prior to joining Maxor, Mr. Ellis was a Corporate Vice President for Walgreen Co. where he was responsible for the specialty pharmacy, infusion and 340B businesses for the past five years. Mr. Ellis held senior management positions in specialty pharmacy and PBM services at AdvancePCS/Caremark/CVS for seven years. Mr. Ellis is also the immediate past President of National Association of Specialty Pharmacy (NASP).
Mr. Ellis is a graduate of the University of Arkansas, from which he received a degree in Pharmacy.
Maxor Founder Jerry Hodge commented, “I would like to thank John for his 40 years of friendship and I am deeply grateful for John’s leadership over the last twelve years. He established a strong culture at the Company and contributed meaningfully to Maxor’s significant growth during this period.”
“Mike Ellis is the perfect individual to take over as CEO of Maxor. I have known Mike for twenty eight years and believe his background in pharmacy will be ideal for Maxor and its customers,” Mr. Hodge added.
Mr. Ellis said, “I am anxious to build on the foundation established by Jerry and John. Maxor is fortunate to have smart, energetic employees and strong, loyal customers. I expect this new chapter of the Company’s 50‐year history will be a continuation of exceptional customer service and growth for which Maxor is known.”
ABOUT MAXOR
Maxor is a leading pharmacy services platform that consists of four primary business segments: (i) pharmacy benefit management (“PBM”), (ii) outpatient pharmacy management, (iii) specialty pharmacy services and (iv) correctional pharmacy services. These segments provide complementary services that aim to improve the health of patients and efficiently manage pharmacy expenditures for its clients.
CONTACT: Gilbert D’Andria, [email protected]
